1. Home
  2. RLMD vs EMF Comparison

RLMD vs EMF Comparison

Compare RLMD & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

SELL

Current Price

$3.06

Market Cap

348.8M

Sector

Health Care

ML Signal

SELL

Logo Templeton Emerging Markets Fund

EMF

Templeton Emerging Markets Fund

SELL

Current Price

$19.46

Market Cap

335.9M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
RLMD
EMF
Founded
2004
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
348.8M
335.9M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
RLMD
EMF
Price
$3.06
$19.46
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $10.75
N/A
AVG Volume (30 Days)
★ 1.7M
22.8K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
★ 6.16%
EPS Growth
★ 45.28
N/A
EPS
N/A
★ N/A
Revenue
★ $13,070.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 154.83
N/A
52 Week Low
$3.07
$16.12
52 Week High
$8.00
$24.70

Technical Indicators

Market Signals
Indicator
RLMD
EMF
Relative Strength Index (RSI) 37.32 28.69
Support Level N/A $16.67
Resistance Level $3.55 $22.97
Average True Range (ATR) 0.43 0.50
MACD -0.04 -0.09
Stochastic Oscillator 4.05 3.48

Price Performance

Historical Comparison
RLMD
EMF

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

About EMF Templeton Emerging Markets Fund

Templeton Emerging Markets Fund is a closed-end management investment company that seeks long-term capital appreciation by investing mainly in emerging country equity securities under normal market conditions. It invests across various sectors, including Pharmaceuticals, Beverages, Broadline Retail, Metals & Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, Insurance, Entertainment, and others.

Share on Social Networks: